PR 1036654
Alternative Names: PR 1036654FBLatest Information Update: 22 Aug 2007
At a glance
- Originator Fisons
- Class Antiallergics; Antihistamines
- Mechanism of Action Histamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 04 Mar 1997 No-Development-Reported for Asthma in USA (Unknown route)